Cargando…
Understanding and Controlling Sialylation in a CHO Fc-Fusion Process
A Chinese hamster ovary (CHO) bioprocess, where the product is a sialylated Fc-fusion protein, was operated at pilot and manufacturing scale and significant variation of sialylation level was observed. In order to more tightly control glycosylation profiles, we sought to identify the cause of variab...
Autores principales: | Lewis, Amanda M., Croughan, William D., Aranibar, Nelly, Lee, Alison G., Warrack, Bethanne, Abu-Absi, Nicholas R., Patel, Rutva, Drew, Barry, Borys, Michael C., Reily, Michael D., Li, Zheng Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911072/ https://www.ncbi.nlm.nih.gov/pubmed/27310468 http://dx.doi.org/10.1371/journal.pone.0157111 |
Ejemplares similares
-
Increased MSX level improves biological productivity and production stability in multiple recombinant GS CHO cell lines
por: Tian, Jun, et al.
Publicado: (2020) -
Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
por: Sowa, Steven W., et al.
Publicado: (2020) -
Production of IgGs with a human-like sialylation in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015) -
Production of α2,6-sialylated IgG1 in CHO cells
por: Raymond, Céline, et al.
Publicado: (2015) -
Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis
por: Kwak, Chan-Yeong, et al.
Publicado: (2017)